Shoulder Innovations Inc

SI

13.860USD

-0.540-3.75%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

Shoulder Innovations Inc's Score

Industry at a Glance

Industry Ranking

136 / 208

Overall Ranking

365 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Shoulder Innovations Inc Highlights

StrengthsRisks

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 145.50% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 47.32M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 47.32M.

Undervalued

The company’s latest PE is -9.82, at a low 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 220.43K shares of this stock.

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

20.500

Target Price

+42.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Shoulder Innovations Inc is 6.75, ranking 116 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.75

Change

0



Financials

8.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.64

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.21

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.33

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

No valuation score is currently available for Shoulder Innovations Inc. The Healthcare Equipment & Supplies industry's average is 7.17. Its current P/E ratio is -9.82, which is -82.43% below the recent high of -1.73 and -10.25% above the recent low of -10.83.

Score

Industry at a Glance

Previous score

0.00

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 136/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Shoulder Innovations Inc is 9.00, ranking 8 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 20.00, with a high of 23.00 and a low of 18.00.

Score

Industry at a Glance

Previous score

9.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Shoulder Innovations Inc is 3.76, ranking 195 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 15.52 and the support level at 12.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.87

Change

-0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

3.83M

-0.59%

U.S. Venture Partners

2.69M

--

Gilde Healthcare Partners B.V.

2.38M

+4.39%

Lightstone Ventures, L.P.

1.89M

+16.48%

Cultivate(MD) Holdings LLC

1.36M

-0.00%

Arboretum Ventures, Inc.

1.16M

+16.64%

Sectoral Asset Management Inc.

430.28K

--

TimesSquare Capital Management, LLC

382.37K

+1753.72%

BlackRock Institutional Trust Company, N.A.

263.12K

--

Ahearn (Matthew Fraser)

282.62K

+61.24%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Shoulder Innovations Inc is 2.87, ranking 141 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Shoulder Innovations Inc

SI

5.03 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment